Clinical Trial Update: Exisulind Prior to Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Exisulind prior to radical prostatectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Exisulind (exisulind)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED